---
figid: PMC8882813__10.1177_17588359211072703-fig2
figtitle: Precision medicine for metastatic colorectal cancer in clinical practice
organisms:
- NA
pmcid: PMC8882813
filename: 10.1177_17588359211072703-fig2.jpg
figlink: /pmc/articles/PMC8882813/figure/fig2-17588359211072703/
number: F2
caption: Targeting the MAPK pathway in colorectal cancer. Druggable receptors and
  intracellular signaling components of the pathway are depicted. Drugs targeting
  the pathway discussed in the text are highlighted.T-DM1, trastuzumab emtansine;
  T-DXd, trastuzumab deruxtecan.
papertitle: Precision medicine for metastatic colorectal cancer in clinical practice.
reftext: Julian E. Riedesser, et al. Ther Adv Med Oncol. 2022;14:17588359211072703.
year: '2022'
doi: 10.1177/17588359211072703
journal_title: Therapeutic Advances in Medical Oncology
journal_nlm_ta: Ther Adv Med Oncol
publisher_name: SAGE Publications
keywords: chemotherapy | colorectal cancer | consensus molecular subtypes | immunotherapy
  | organoids | patient-derived xenografts | personalized oncology | precision medicine
  | targeted therapy
automl_pathway: 0.9459903
figid_alias: PMC8882813__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC8882813__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8882813__10.1177_17588359211072703-fig2.html
  '@type': Dataset
  description: Targeting the MAPK pathway in colorectal cancer. Druggable receptors
    and intracellular signaling components of the pathway are depicted. Drugs targeting
    the pathway discussed in the text are highlighted.T-DM1, trastuzumab emtansine;
    T-DXd, trastuzumab deruxtecan.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Sos
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Egfr
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Mtor
  - Tor
---
